Hotspot Diagnostics utilizing genomic biomarkers that are specific for sun exposure to develop a diagnostic blood test that can identify traces of skin cell DNA in the blood circulation. Identifying these cells can be used for early diagnosis of skin cancer or detecting disease relapse after treatment, alone or in combination with other biomarkers.
Impact: Reduce patient suffering/mortality and healthcare expenses
GUV Contact: Lorna Fletcher